Glaukos Revenue 2014-2022 | GKOS

Glaukos revenue from 2014 to 2022. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Glaukos Annual Revenue
(Millions of US $)
2021 $294
2020 $225
2019 $237
2018 $181
2017 $159
2016 $114
2015 $72
2014 $46
2013 $21
Glaukos Quarterly Revenue
(Millions of US $)
2022-09-30 $71
2022-06-30 $73
2022-03-31 $68
2021-12-31 $73
2021-09-30 $75
2021-06-30 $78
2021-03-31 $68
2020-12-31 $73
2020-09-30 $65
2020-06-30 $32
2020-03-31 $55
2019-12-31 $66
2019-09-30 $59
2019-06-30 $59
2019-03-31 $54
2018-12-31 $54
2018-09-30 $44
2018-06-30 $43
2018-03-31 $40
2017-12-31 $42
2017-09-30 $40
2017-06-30 $41
2017-03-31 $36
2016-12-31 $33
2016-09-30 $30
2016-06-30 $29
2016-03-31 $23
2015-12-31 $20
2015-09-30 $19
2015-06-30 $18
2015-03-31 $15
2014-12-31 $14
2014-09-30 $12
2014-06-30 $11
2014-03-31 $8
2013-12-31
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $2.263B $0.294B
Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company. Glaukos is focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Glaukos developed Micro Invasive Glaucoma Surgery to serve as an alternative to the traditional glaucoma treatment and management paradigms. The company's iStent platform is the first MIGS device in the United States. Glaukos markets its products through direct sales force in the United States and other countries. It has distribution partners in Europe, the Asia Pacific, Latin America, and internationally.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $214.645B 22.45
Edwards Lifesciences (EW) United States $46.932B 32.30
Alcon (ALC) Switzerland $33.321B 28.69
STERIS (STE) Ireland $18.019B 22.42
Teleflex (TFX) United States $10.587B 17.18
Fresenius Medical Care AG KGaA (FMS) Germany $8.996B 9.03
Penumbra (PEN) United States $7.452B 1783.82
Globus Medical (GMED) United States $7.103B 36.11
Integer Holdings (ITGR) United States $2.367B 19.00
Nevro (NVRO) United States $1.556B 0.00
Paragon 28 (FNA) United States $1.534B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.246B 17.74
Artivion (AORT) United States $0.520B 0.00